1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Italy >
  5. Donaldson Invests In Medica

Investment Summary

Donaldson Invests In Medica

On April 29, 2024, Donaldson invested in medical products company Medica

Investment Highlights
  • This is Donaldson’s 1st transaction in the Medical Products sector.
  • This is Donaldson’s 2nd transaction in Italy.

Investment Summary
Date 2024-04-29
Target Medica
Sector Medical Products
Investor(s) Donaldson
Deal Type Stake Purchase

Target

Medica

Medolla, Italy
Medica provides hollow fiber membrane filtration technology for medical device applications and water purification. The company's hollow fiber membrane filtration products are used for blood purification in numerous applications including dialysis, continuous renal replacement therapies (CRRT), and therapeutic apheresis. Medica was formed in 1985 and is based in Medolla, Italy.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Donaldson

Bloomington, Minnesota, United States
Category Company
Founded 1915
Sector Machinery
Employees14,000
Revenue 3.6B USD (2024)
DESCRIPTION
Donaldson's corporate headquarters in Minneapolis, Minnesota.
Donaldson's corporate headquarters in Minneapolis, Minnesota.

Donaldson is a provider of filtration systems and replacement parts. Donaldson is a technology-driven company committed to satisfying customer needs for filtration solutions through innovative research and development. Donaldson was incorporated in 1915 and is based in Bloomington, Minnesota.

DEAL STATS #
Overall 17 of 17
Sector: Medical Products M&A 1 of 1
Type: Stake Purchase M&A Deals 2 of 2
Country: Italy M&A 2 of 2
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-29 Univercells

Nivelles, Belgium

Univercells is a producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing. The Company offers a comprehensive technology portfolio leveraging the strengths of process intensification and chaining as a direct answer to the growing demand of viral vectors and viral vaccines. Univercells is based in Nivelles, Belgium.

Buy -
Mergr

Solution for

Product

Company

Legal